Shetye J D, Rubio C A, Wallin B, Mellstedt H
Department of Pathology, Karolinska Hospital, Stockholm, Sweden.
In Vivo. 1994 Mar-Apr;8(2):191-8.
Thirty-five adult male Sprague-Dawley rats received weekly subcutaneous injections of 1,2-dimethylhydrazine (DMH) for 12 weeks. At the end of this period, 31 rats had developed colonic carcinomas (CC). A fragment (1 mm3) of each CC was autotransplanted into the subcapsular space of the left kidney of the respective rats. After an additional 3 weeks, the rats were sacrificed. The left kidney in 20 of the 31 rats (65%) demonstrated tumors at the site of transplantation. The transplanted tumors demonstrated markers of viability such as a PCNA positive cells, mitotic figures, mucin secretion, neo-vascularization, invasion of the adjacent kidney tissue and infiltration of mononuclear cells. The frequency of tumor cells exhibiting the tumor associated antigens CO17-1A, GA73-3, BR55-2, GICA 19-9 was similar or higher in most of the autotransplants when compared to the donor tumor. Since MAb17-1A is being used in immunotherapy of metastatic CC in humans, the present model may offer a feasible method to assess various biotherapeutic approaches of metastatic CC based on the use of MAb17-17A.
35只成年雄性Sprague-Dawley大鼠每周皮下注射1,2-二甲基肼(DMH),持续12周。在此期间结束时,31只大鼠发生了结肠癌(CC)。将每只CC的一个碎片(1立方毫米)自体移植到相应大鼠左肾的肾包膜下间隙。再过3周后,处死大鼠。31只大鼠中有20只(65%)的左肾在移植部位出现肿瘤。移植肿瘤表现出存活标志物,如增殖细胞核抗原(PCNA)阳性细胞、有丝分裂象、粘蛋白分泌、新生血管形成、侵袭相邻肾组织以及单核细胞浸润。与供体肿瘤相比,大多数自体移植肿瘤中表现出肿瘤相关抗原CO17-1A、GA73-3、BR55-2、GICA 19-9的肿瘤细胞频率相似或更高。由于MAb17-1A正在用于人类转移性CC的免疫治疗,本模型可能提供一种可行的方法,以评估基于MAb17-17A使用的转移性CC的各种生物治疗方法。